Detecting synovitis by clinical examination is difficult, even though clinical examination is currently the gold standard for diagnosing synovitis in rheumatic diseases -- especially rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . In patients with early psoriatic arthritis who are naïve to disease-modifying antirheumatic drugs, swollen ...

Unlike synovitis, the presence of joint effusions on MRI among patients with hand osteoarthritis (OA) was not associated with pain or progression, Dutch researchers reported. Pain in a specific joint ...

To address these issues, Le Boedec and colleagues performed simultaneous clinical joint examination and ultrasound to assess synovitis and evaluated the factors that were associated with concordance ...

Easily assessed clinical signs of joint and tendon involvement early in the course of systemic sclerosis (SSc) can help predict disease progression, a prospective European study found. The presence of ...

The exact cause of polymyalgia rheumatica (PMR) is unknown. Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary arteries ...

Subclinical synovitis is significantly more common among patients with psoriasis without musculoskeletal involvement than healthy controls, according to a review published online July 16 in JAMA ...

Novartis’ interleukin-17A (IL-17A) Cosentyx (secukinumab) demonstrated early synovitis reduction in patients with active psoriatic arthritis in the phase IIIb ULTIMATE study. Synovitis, or joint ...

Please provide your email address to receive an email when new articles are posted on . A 60-year-old woman presented to us with newly diagnosed breast cancer. She had a screening mammogram that ...

Lady Gaga fans weren’t happy to learn a new word this week: “synovitis.” That’s the reason the Mother Monster gave for cancelling the remaining dates on the American leg of her global stadium tour.

Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma.